Vivimed Labs Limited [VIVIMEDLAB] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Vivimed Labs Limited

NSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vivimed Labs Limited wins in 4 metrics, Sun Pharmaceutical Industries Ltd. wins in 14 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vivimed Labs Limited Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) -1.74 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio -1.16 5.15 Sun Pharmaceutical Industries Ltd.
Debt-to-Equity Ratio -8.01 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio -0.01 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA -46.90 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) -39.54% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) -97.25% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) N/A 26.17% N/A
Return on Equity 90.88% 15.08% Vivimed Labs Limited
Return on Assets (TTM) -3.47% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-62.82M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return 35.76% 7.25% Vivimed Labs Limited
Price-to-Sales Ratio (TTM) 0.64 7.05 Vivimed Labs Limited
Enterprise Value $4.40B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 4.98 6.66 Vivimed Labs Limited
Gross Profit Margin (TTM) 50.60% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $11 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $-4.21 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.74 0.11 Sun Pharmaceutical Industries Ltd.

Vivimed Labs Limited vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

VIVIMEDLAB
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vivimed Labs Limited-0.93%-0.93%-7.79%-7.79%29.09%-61.94%
Sun Pharmaceutical Industries Ltd.-0.08%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vivimed Labs Limited35.76%16.87%-77.60%-91.57%-88.66%-81.43%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Vivimed Labs Limited vs Sun Pharmaceutical Industries Ltd.

MetricVIVIMEDLABSUNPHARMA
Market Information
Market Cap i₹556.35M₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i139,7913,903,142
90 Day Avg. Volume i155,6623,253,866
Last Close₹6.39₹1,788.50
52 Week Range₹4.95 - ₹29.40₹1,548.00 - ₹1,916.60
% from 52W High-78.27%-6.68%
All-Time High₹248.80 (Apr 24, 2006)₹1,960.35 (Sep 30, 2024)
% from All-Time High-97.43%-8.77%
Growth Metrics
Quarterly Revenue Growth-0.56%0.14%
Quarterly Earnings Growth-0.56%0.16%
Financial Health
Profit Margin (TTM) i-0.40%0.19%
Operating Margin (TTM) i-0.97%0.26%
Return on Equity (TTM) i0.91%0.15%
Debt to Equity (MRQ) i-8.016.68
Cash & Liquidity
Book Value per Share (MRQ)₹-5.78₹324.46
Cash per Share (MRQ)₹0.12₹115.87
Operating Cash Flow (TTM) i₹-172,560,000₹110.84B
Levered Free Cash Flow (TTM) i₹-319,610,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend i₹0.00₹16.50

Valuation & Enterprise Metrics Analysis: Vivimed Labs Limited vs Sun Pharmaceutical Industries Ltd.

MetricVIVIMEDLAB (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-1.7436.73
Forward P/E iN/A29.48
PEG Ratio i-0.013.59
Price to Sales (TTM) i0.647.05
Price to Book (MRQ) i-1.165.15
Market Capitalization
Market Capitalization i₹556.35M₹3.88T
Enterprise Value i₹4.40B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i4.986.66
Enterprise to EBITDA i-46.9023.61
Risk & Other Metrics
Beta i0.740.11
Book Value per Share (MRQ) i₹-5.78₹324.46

Financial Statements Comparison: Vivimed Labs Limited vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVIVIMEDLAB (2025)SUNPHARMA (2025)
Revenue/Sales i1.16B520.41B
Cost of Goods Sold i636.23M121.98B
COGS % of Revenue i54.7%23.4%
Gross Profit i526.46M398.44B
Gross Margin i45.3%76.6%
Research & Development i4.22MN/A
Operating Income (EBIT) i-290.03M125.81B
Operating Margin i-24.9%24.2%
EBITDA i-98.87M167.25B
EBITDA Margin i-8.5%32.1%
Pre-Tax Income i-318.48M137.52B
Pre-Tax Income % of Revenue i-27.4%26.4%
Income Tax i1.13M27.72B
Income Tax % of Revenue i0.1%5.3%
Net Income (Profit) i-319.61M109.65B
Profit Margin i-27.5%21.1%

Balance Sheet & Liquidity Metrics

MetricVIVIMEDLAB (2025)SUNPHARMA (2025)
Cash & Equivalents i7.08M102.69B
Total Current Assets i3.28B526.24B
Total Current Assets % of Revenue i281.7%101.1%
Total Current Liabilities i4.08B181.94B
Total Current Liabilities % of Revenue i351.1%35.0%
Long-Term Debt i636.15M3.58B
Long-Term Debt % of Revenue i54.7%0.7%
Total Shareholders Equity i-351.69M724.86B
Retained Earnings i-3.22B578.62B
Retained Earnings % of Revenue i-277.2%111.2%
Property, Plant & Equipment i340.80M100.36B

Cash Flow Statement Comparison

MetricVIVIMEDLAB (2025)SUNPHARMA (2025)
Operating Cash Flow i-172.56M110.84B
Operating Cash Flow % of Revenue i-14.8%21.3%
Capital Expenditures i-45.31M-20.68B
Free Cash Flow i-62.82M119.44B
FCF Margin i-5.4%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricVIVIMEDLABSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i82.91M2.40B
Float Shares i64.55M1.07B
% Held by Insiders i16.75%55.62%
% Held by Institutions i10.84%28.69%
% Held by Public i72.41%15.69%

Dividend Analysis & Yield Comparison: Vivimed Labs Limited vs Sun Pharmaceutical Industries Ltd.

MetricVIVIMEDLABSUNPHARMA
Last 12-Month Dividend i₹0.00₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend i₹0.00₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends i₹0.00₹52.00
Ex-Dividend DateN/AFeb 05, 2026